Drugs / Nitroketazine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04950647 | Jul 2020 → Jul 2022 | amyotrophic lateral sclerosis | Peking University Third Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nitroketazine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04950647 ↗ |
| Route | Oral | “each oral Nitroketazine 300 mg tablets x4 tablets” NCT04950647 ↗ |